NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JMACCT ID: JMA-IIA00139

Registered date:19/09/2013

The observation of the changes of iron metabolic and oxidative stress markers after intravenous injection in HD patients

Basic Information

Recruitment status Other
Health condition(s) or Problem(s) studiedHemodialysis patients
Date of first enrollment18/09/2013
Target sample size20
Countries of recruitmentJapan
Study typeOBSERVATIONAL
Intervention(s)

Outcome(s)

Primary OutcomeChange of serum concentration of iron metabolic markers after intravenous injectin of saccharated ferricoxide.
Secondary Outcome.

Key inclusion & exclusion criteria

Age minimumNo Limit
Age maximumNo Limit
GenderBOTH
Include criteriaHD patients
Exclude criteria

Related Information

Contact

public contact
Name Shigeru miyazaki
Address Nephrology,Shindoori-minami 3-3-11, Nshi-ku, Niigata, 950-2087 Japan
Telephone +81-25-260-8200
E-mail byori@shinrakuen.com
Affiliation Shinraku-en Hospital
scientific contact
Name Shigeru miyazaki
Address Nephrology,Shindoori-minami 3-3-11, Nshi-ku, Niigata, 950-2087 Japan
Telephone +81-25-260-8200
E-mail
Affiliation Shinraku-en Hospital